Figure 3From: PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanomaStable modification of ADSCs and melanoma B16f10 cells with the use of DNA integrating vectors. A) Flow cytometric analysis of EGFP expression by ADSCs. (Left plot) Mean percentage of EGFP-expressing ADSCs post 48 h of nucleofection with pmaxGFP vector, indicating efficient transgene transfer into mouse ADSCs. (Right plot) Mean percentage of EGFP-positive ADSCs two weeks after nucleofection with pmhy GENIE-3 and hygromycin selection. Results are representatives of triplicate experiments. B) Fluorescence microscopy image of EGFP-expressing ADSCs after nucleofection with pmhy GENIE-3 and two weeks selection with hygromycin. C) Stable RFP-expressing melanoma cells after lipofection with pDsRed-attb-zeo/pCMVInt and three weeks of zeocin selection. D) EGFP-expressing melanoma cells after lipofection with pBEB/pCMVInt and three weeks of geneticin selection. E) Western blot analysis of IFNγ from ADSC cell lysates. Modified ADSCs were selected with hygromycin following nucleofection with either pmhy GENIE-3 (Lane 1) or pmhy GENIE-3-IFNγ (Lane 2). Blotting was performed using a monoclonal antibody against mouse IFNγ. F) Cytofluorimetric evaluation of TRAIL expression in ADSCs selected with geneticin following co-nucleofection with pBEB/pCMVInt (Violet histograms) and pBTB/pCMVInt (white histograms). ADSCs were stained with a PE conjugated monoclonal antibody to mouse TRAIL. A single representative experiment of triplicates is shown. (Left plot) Surface staining of TRAIL-ADSCs after 48 h of co-nucleofection. (Right plot) Surface staining of TRAIL-ADSCs after co-nucleofection and three weeks of geneticin selection. PE = phycoerythrin.Back to article page